# Trial Library

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/trial-library

- Industry: Healthcare
- Headquarters: San Francisco, US
- Website: www.triallibrary.com/
- Total disclosed funding: $15M
- Latest round: Series A (Dec 3, 2025)
- Investors on record: 7

## About

Based in California, US, and co-founded in 2022 by Hala Borno (CEO), and Steve Buck, Trial Library, Inc. is an oncology clinical trials company with a mission to improve health equity by expanding access to cancer precision medicine. In December 2025, Trial Library, Inc. raised USD10 million in series A funding co-led by  SemperVirens and Next Ventures, with participation from Sanofi Ventures and Lux Capital. 

The company provides a healthcare research-based platform that enables diagnoses and treatment of cancer patients as well as engages them in clinical trials with patient navigation assistance together with tools to address social determinants of health (SDoH). Patients can be engaged wherever they are in the treatment process with the trained Ally Navigators offered by the firm.

## Funding rounds

- Series A, Dec 3, 2025, $10M — Lux Capital, Sanofi Ventures, Next Ventures, SemperVirens
- Seed, Aug 18, 2022, $5M — Lux Capital, Incite Ventures, Karman Ventures, Next Ventures, Unseen Capital

## Investors

- Lux Capital (https://capitalatlas.ai/funds/lux-capital) — Seed, Series A
- Incite Ventures (https://capitalatlas.ai/funds/incite-ventures) — Seed
- Karman Ventures (https://capitalatlas.ai/funds/karman-ventures) — Seed
- Next Ventures (https://capitalatlas.ai/funds/next-ventures) — Seed, Series A
- Unseen Capital (https://capitalatlas.ai/funds/unseen-capital) — Seed
- Sanofi Ventures (https://capitalatlas.ai/funds/sanofi-ventures) — Series A
- SemperVirens (https://capitalatlas.ai/funds/sempervirens) — Series A